| Name | Olacaftor |
|---|---|
| Synonyms |
Olacaftor
6-(3-Fluoro-5-isobutoxyphenyl)-N-(phenylsulfonyl)-2-(2,2,4-trimethyl-1-pyrrolidinyl)nicotinamide 3-Pyridinecarboxamide, 6-[3-fluoro-5-(2-methylpropoxy)phenyl]-N-(phenylsulfonyl)-2-(2,2,4-trimethyl-1-pyrrolidinyl)- |
| Description | Olacaftor (VX-440, VX440) is a next-generation CFTR corrector, shows the potential to enhance the amount of CFTR protein at the cell’s surface and for treatment of cystic fibrosis. Fibrosis Phase 2 Clinical |
|---|---|
| References | References View Related Products by Target CFTR Fibrosis |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C29H34FN3O4S |
| Molecular Weight | 539.661 |
| Exact Mass | 539.225403 |
| LogP | 6.43 |
| Index of Refraction | 1.563 |